Increased activity of SIRT1 leads to upregulation of resistance-promoting genes in drug-resistant cancer cell lines, whereas inhibition of SIRT1 with siRNA reduces cell resistance (Moore et al. 2012; Chu et al. 2005). The gene discussed is SIRT1; the disease is cancer.